Is Low-Risk Prostate Cancer More Indolent in Younger Patients?

被引：1
|
作者：
Garzotto, Mark [1 ,2 ]
机构：
[1] Vet Adm Portland Hlth Care Syst, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 17期
关键词：
RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; MEN; METHYLATION;
D O I：
10.1200/JCO.2017.72.3684
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1870 / +
页数：4
相关论文
共 50 条
  • [31] UNILATERAL PROSTATE CANCER CANNOT BE ACCURATELY PREDICTED IN LOW-RISK PATIENTS
    Isbarn, Hendrik
    Karakiewicz, Pierre I.
    Vogel, Susanne
    Jeldres, Claudio
    Lughezzani, Giovanni
    Briganti, Alberto
    Montorsi, Francesco
    Perrotte, Paul
    Ahyai, Sascha A.
    Budaeus, Lars
    Eichelberg, Christian
    Heuer, Roman
    Koellermann, Jens
    Sauter, Guido
    Schlomm, Thorsten
    Steuber, Thomas
    Haese, Alexander
    Zacharias, Mario
    Fisch, Margit
    Heinzer, Hans
    Huland, Hartwig
    Chun, Felix K. H.
    Graefen, Markus
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (03): : 784 - 787
  • [32] Predictors of ISUP score upgrade in patients with low-risk prostate cancer
    Haberal, Hakan Bahadir
    Artykov, Meylis
    Hazir, Berk
    Citamak, Burak
    Altan, Mesut
    Yazici, Sertac
    Akdogan, Bulent
    Ozen, Haluk
    [J]. TUMORI JOURNAL, 2021, 107 (03): : 254 - 260
  • [33] Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
    Flammia, Rocco S.
    Hoeh, Benedikt
    Hohenhorst, Lukas
    Sorce, Gabriele
    Chierigo, Francesco
    Panunzio, Andrea
    Tian, Zhe
    Saad, Fred
    Leonardo, Costantino
    Briganti, Alberto
    Antonelli, Alessandro
    Terrone, Carlo
    Shariat, Shahrokh F.
    Anceschi, Umberto
    Graefen, Markus
    Chun, Felix K. H.
    Montorsi, Francesco
    Gallucci, Michele
    Karakiewicz, Pierre, I
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (10) : 2521 - 2528
  • [34] Enzalutamide versus active Surveillance in Patients with Low-risk Prostate Cancer
    Dunst, Juergen
    Krug, David
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (02) : 201 - 203
  • [35] Low-Risk Prostate Cancer Patients on Active Surveillance: Utility of Immunohistochemistry
    Poveda, J.
    Eldefrawy, A.
    Umar, S.
    Soloway, M.
    Jorda, M.
    [J]. MODERN PATHOLOGY, 2013, 26 : 241A - 241A
  • [36] Treatment options for low-risk prostate cancer
    Song, Yuxuan
    Xu, Tao
    [J]. WORLD JOURNAL OF UROLOGY, 2022, 40 (11) : 2827 - 2828
  • [37] Treatment options for low-risk prostate cancer
    Yuxuan Song
    Tao Xu
    [J]. World Journal of Urology, 2022, 40 : 2827 - 2828
  • [38] Physicians' perspectives on the informational needs of low-risk prostate cancer patients
    Hagerman, Charlotte J.
    Bellini, Paula G.
    Davis, Kim M.
    Hoffman, Richard M.
    Aaronson, David S.
    Leigh, Daniel Y.
    Zinar, Riley E.
    Penson, David
    Van Den Eeden, Stephen
    Taylor, Kathryn L.
    [J]. HEALTH EDUCATION RESEARCH, 2017, 32 (02) : 134 - 152
  • [39] Small Renal Mass and Low-Risk Prostate Cancer: Any More for Active Surveillance?
    Yates, David R.
    Roupret, Morgan
    [J]. EUROPEAN UROLOGY, 2011, 60 (01) : 45 - 47
  • [40] Low-risk essential thrombocythaemia in patients younger than 40
    Randi, ML
    Luzzatto, G
    Fabris, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) : 929 - 929
12345